CHRISTOPHER BUNKA - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
29 Jul 2025
Net transactions value
+$25,241
Form type
4
Filing time
30 Jul 2025, 17:12:54 UTC
Previous filing
16 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BUNKA CHRISTOPHER Director SUITE 100, 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA /Chris Bunka/ 30 Jul 2025 0001103780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $14,375 +15,600 +6.1% $0.9215 270,012 29 Jul 2025 Private Holding Company
transaction LEXX common shares Purchase $10,866 +11,900 +4.4% $0.9131 281,912 30 Jul 2025 Private Holding Company
holding LEXX common shares 373,543 29 Jul 2025 Direct
holding LEXX common shares 254,412 29 Jul 2025 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 26,000 29 Jul 2025 Common Shares 26,000 $3.00 Direct
holding LEXX Stock Options 49,334 29 Jul 2025 Common Shares 23,334 $3.00 Direct
holding LEXX Stock Options 64,334 29 Jul 2025 Common Shares 15,000 $3.00 Direct
holding LEXX Stock Options 94,334 29 Jul 2025 Common Shares 30,000 $2.91 Direct
holding LEXX Stock Options 124,334 29 Jul 2025 Common Shares 30,000 $1.15 Direct
holding LEXX Stock Options 173,834 29 Jul 2025 Common Shares 49,500 $2.36 Direct
holding LEXX Stock Options 184,834 29 Jul 2025 Common Shares 11,000 $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.